Neogenix Oncology Inc — Form D

Neogenix Oncology Inc of Great Neck, NY, a company, filed a Form D exempt-offering notice with the SEC on 2009-05-22. The offering totals $15.0M. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
William AshtonDirectorPhiladelphia, PA
Thomas LytleDirectorGreat Neck, NY
Rishab GuptaExecutive OfficerGreat Neck, NY
Thomas LytleExecutive OfficerGreat Neck, NY
Peter GordonDirectorDublin, OH
Peter GordonExecutive OfficerDublin, OH
Peter GordonPromoterDublin, OH
PHILIP ARLENDirectorMiami, FL
PHILIP ARLENExecutive OfficerMiami, FL
J. Douglas HolladayDirectorKnoxville, TN
Lynn KromingaDirectorGreat Neck, NY
Barry GauseDirectorGreat Neck, NY
Myron ArlenDirectorGreat Neck, NY
Myron ArlenExecutive OfficerGreat Neck, NY
Myron ArlenPromoterGreat Neck, NY
James FeldmanDirectorGreat Neck, NY
Timothy P ShriverDirectorWashington, DC
Dennis GreeneDirectorGreat Neck, NY
William K AshtonDirectorPhiladelphia, PA
Rishab K GuptaExecutive OfficerGreat Neck, NY
David S MoskowitzDirectorNew York, NY
Thomas K LytleDirectorGreat Neck, NY
Thomas K LytleExecutive OfficerGreat Neck, NY
Phillip ArlenDirectorGreat Neck, NY
Phillip ArlenExecutive OfficerGreat Neck, NY

Other filings by this issuer (3)

FiledFormOfferingSold
2010-10-08D$40.0M$846K
2009-12-15D$50.0M
2009-05-15D$15.0M$15.0M

More